Administration of L-1 to mice bearing MC38 or CT26 tumors substantially suppresses tumor growth, particularly when combined with anti-PD-L1, and augments the presence of tumor-associated macrophages as well as CD8+ and CD4+ T cells. Here, CD4 is linked to neoplasm.